![Julie Grant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Grant
Directeur/Membre du Conseil chez
Nocion Therapeutics, Inc.
Profil
Julie Grant was the founder of Day One Biopharmaceuticals, Inc. (founded in 2018) and served as an Independent Director from 2022 to 2023.
Ms. Grant is also the founder of DOT Therapeutics-2, Inc...
Ms. Grant's current job(s) include being a Director at Protagonist Pty Ltd., Nocion Therapeutics, Inc., Synthekine, Inc., and General Partner at Canaan Management, Inc. Ms. Grant's former job(s) include being an Independent Director at Protagonist Therapeutics, Inc. from 2015 to 2017, Principal at Genentech, Inc. and Labrys Biologics, Inc., and a Board Member at Biden Cancer Initiative, Inc. from 2017 to 2018.
Ms. Grant's education history includes a graduate degree from the University of Cambridge in 2006, an undergraduate degree from Yale University in 2005, and an MBA from Stanford Graduate School of Business in 2013.
Postes actifs de Julie Grant
| Sociétés | Poste | Début |
|---|---|---|
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Analyste en capital-investissement | 01/01/2013 |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Directeur/Membre du Conseil | 01/02/2018 |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Directeur/Membre du Conseil | 01/03/2019 |
Anciens postes connus de Julie Grant
| Sociétés | Poste | Fin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Général | 01/09/2020 |
Biden Cancer Initiative, Inc. | Directeur/Membre du Conseil | 01/11/2018 |
| PROTAGONIST THERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/12/2017 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Fondateur | - |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Corporate Officer/Principal | - |
Formation de Julie Grant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management invests in companies located in the United States. The firm focuses on companies such as consumer, fintech, enterprise/cloud, biopharmaceuticals, medical technology and digital health. It participates in early-stage capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Biden Cancer Initiative, Inc. | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Choisissez Zonebourse 
